The effect of intravenous meperdine vs intratechal meperdine on shivering during delivery under spinal anaesthesia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201301261936N11

Enrollment

Registered

2013-02-06

Start date

2013-02-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering after delivery. Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention 1: Control group received 12.5 mg bupivacaine 0.05, intratechaly plus 12.5 mg pethidine, intratechaly up to 3 cc. Intervention 2: Intervention group receive 12.5 mg bupivacaine 0.05, intr

Treatment - Drugs

Control group received 12.5 mg bupivacaine 0.05, intratechaly plus 12.5 mg pethidine, intratechaly up to 3 cc

Intervention group receive 12.5 mg bupivacaine 0.05, intratechaly plus 0.5 cc of normal saline up to 3 cc plus 12.5 mg pethidine, intravenously

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all women age between 15 and 45 years who are candidates for caesarean section and signed informed consent are eligible to join the study. Exclusion criteria: any contra indication for R/A and those who are sensitive to opioid.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Post spinal shivering. Timepoint: 60 minute. Method of measurement: observation.	—

Secondary

Measure	Time frame
Post operative nausea and vomitting. Timepoint: 45 minute. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Abdolreza Najafianaraki

Bushehr University of Medical Sciences

dr.najafianaraki@gmail.com+98 77 1252 6801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026